However further evidence with immunoglobulin heavy chain gene mutational signatures and immunophenotyping suggest PCNSL has germinal center origin or exposure [31,34,35,36,37] and increasingly, there is evidence PCNSL may demonstrate an overlapping state of differentiation with concurrent expression of germinal center markers such as BCL6 and activation markers such as cyclin D2 or MUM1/Interferon Regulatory Factor 4 (IRF4) [31,38]. Here, SLC3A2 is linked to primary central nervous system lymphoma.